| Dr Kenneth J Szekely, MD | |
|
8775 Norwin Ave, North Huntingdon, PA 15642-2718 | |
| (855) 765-7277 | |
| (724) 863-0046 |
| Full Name | Dr Kenneth J Szekely |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 8775 Norwin Ave, North Huntingdon, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467450254 | NPI | - | NPPES |
| 0017066330007 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD064394L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excela Health Westmoreland Regional Hospital | Greensburg, PA | Hospital |
| Upmc East | Monroeville, PA | Hospital |
| Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Excela Health Latrobe Hospital | Latrobe, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Community Medicine Inc | 2062318975 | 690 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
The Hemophilia and Thrombosis Treatment Center at UC San Diego Health has joined a nationwide clinical trial testing a potential gene therapy that may one day provide a better and long-lasting treatment for people with hemophilia B.
The dynamics of the SARS-CoV-2 pandemic share "striking similarities" with the twin environmental crises of global heating and species extinction, argue a team of scientists and policy experts from the UK and US.
In first-aid situations, wounds must be quickly and effectively closed to stop blood loss and prevent infection. For treatment on arrival in a hospital, the temporary seal must be reopened, which often causes additional damage to the injured tissue. In the journal Angewandte Chemie, American scientists have now introduced a novel gel for sealing wounds. The gel can later be dissolved and gently removed.
As the coronavirus cases skyrocket, many countries have started to ease lockdown measures to save the ailing economy. Restaurants, malls, recreational centers, and transportation are slowly returning to normal operations. However, one of the most heavily impacted sectors amid the pandemic is the aviation industry.
› Verified 4 days ago
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
The Hemophilia and Thrombosis Treatment Center at UC San Diego Health has joined a nationwide clinical trial testing a potential gene therapy that may one day provide a better and long-lasting treatment for people with hemophilia B.
The dynamics of the SARS-CoV-2 pandemic share "striking similarities" with the twin environmental crises of global heating and species extinction, argue a team of scientists and policy experts from the UK and US.
In first-aid situations, wounds must be quickly and effectively closed to stop blood loss and prevent infection. For treatment on arrival in a hospital, the temporary seal must be reopened, which often causes additional damage to the injured tissue. In the journal Angewandte Chemie, American scientists have now introduced a novel gel for sealing wounds. The gel can later be dissolved and gently removed.
As the coronavirus cases skyrocket, many countries have started to ease lockdown measures to save the ailing economy. Restaurants, malls, recreational centers, and transportation are slowly returning to normal operations. However, one of the most heavily impacted sectors amid the pandemic is the aviation industry.
› Verified 4 days ago
| Entity Name | Mon-vale Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669715843 PECOS PAC ID: 4880837772 Enrollment ID: O20130824000072 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
The Hemophilia and Thrombosis Treatment Center at UC San Diego Health has joined a nationwide clinical trial testing a potential gene therapy that may one day provide a better and long-lasting treatment for people with hemophilia B.
The dynamics of the SARS-CoV-2 pandemic share "striking similarities" with the twin environmental crises of global heating and species extinction, argue a team of scientists and policy experts from the UK and US.
In first-aid situations, wounds must be quickly and effectively closed to stop blood loss and prevent infection. For treatment on arrival in a hospital, the temporary seal must be reopened, which often causes additional damage to the injured tissue. In the journal Angewandte Chemie, American scientists have now introduced a novel gel for sealing wounds. The gel can later be dissolved and gently removed.
As the coronavirus cases skyrocket, many countries have started to ease lockdown measures to save the ailing economy. Restaurants, malls, recreational centers, and transportation are slowly returning to normal operations. However, one of the most heavily impacted sectors amid the pandemic is the aviation industry.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth J Szekely, MD 520 Jefferson Ave, Suite 400, Jeannette, PA 15644-2538 Ph: (724) 527-8060 | Dr Kenneth J Szekely, MD 8775 Norwin Ave, North Huntingdon, PA 15642-2718 Ph: (855) 765-7277 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
The Hemophilia and Thrombosis Treatment Center at UC San Diego Health has joined a nationwide clinical trial testing a potential gene therapy that may one day provide a better and long-lasting treatment for people with hemophilia B.
The dynamics of the SARS-CoV-2 pandemic share "striking similarities" with the twin environmental crises of global heating and species extinction, argue a team of scientists and policy experts from the UK and US.
In first-aid situations, wounds must be quickly and effectively closed to stop blood loss and prevent infection. For treatment on arrival in a hospital, the temporary seal must be reopened, which often causes additional damage to the injured tissue. In the journal Angewandte Chemie, American scientists have now introduced a novel gel for sealing wounds. The gel can later be dissolved and gently removed.
As the coronavirus cases skyrocket, many countries have started to ease lockdown measures to save the ailing economy. Restaurants, malls, recreational centers, and transportation are slowly returning to normal operations. However, one of the most heavily impacted sectors amid the pandemic is the aviation industry.
› Verified 4 days ago
Daniel Medic Jr., DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8791 Barnes Lake Rd, Ste 101, North Huntingdon, PA 15642 Phone: 724-864-9400 Fax: 724-864-8044 | |
Keith Szekely, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8775 Norwin Ave, Suite 202, North Huntingdon, PA 15642 Phone: 724-978-7950 | |
Rebecca A Quel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8775 Norwin Ave, North Huntingdon, PA 15642 Phone: 855-765-7277 Fax: 724-863-0046 | |
Clark Kerr, Family Medicine Medicare: Medicare Enrolled Practice Location: 12279 Route 30, North Huntingdon, PA 15642 Phone: 724-864-7101 | |
Dr. Michel P Toret, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Norwin Hill's Office Center, 8775 Norwin Ave, Suite # 107, North Huntingdon, PA 15642 Phone: 724-863-9700 Fax: 724-863-7023 | |
Dr. Thor Christian Mathos, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8775 Norwin Ave, North Huntingdon, PA 15642 Phone: 855-765-7277 Fax: 724-863-0046 | |
Kim R Avolio, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8775 Norwin Ave, North Huntingdon, PA 15642 Phone: 724-765-1168 Fax: 724-765-1241 |